Search clinical trials for: neuropsychiatric symptoms

Total 244924 results

Biohaven Pharmaceuticals, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy (RESILIENT)

Neuromuscular Diseases | Spinal Muscular Atrophy | SMA

United States, Netherlands, United Kingdom, Spain, Czechia, Belgium, Germany, Italy, Poland
Eli Lilly and Company

Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Mild Cognitive Impairment (MCI) | Alzheimer Disease

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Korea, Republic of, Canada, Germany, Japan, Italy, Switzerland
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Canada, Japan, Germany, Korea, Republic of, Switzerland
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
Centre for Addiction and Mental Health
University of Calgary; Lawson Health Research Institute; Douglas Mental Health...

Active, not recruiting

Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia (StaN)

Aggression | Alzheimer's Disease | Alzheimer Dementia (AD)

Canada
H. Lundbeck A/S

Completed

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments (DELIVER)

Migraine

Spain, United States, Bulgaria, Hungary, Germany, Poland, Georgia, Belgium, Finland, Czechia, Denmark, France, Italy, Russian Federation, Slovakia, Sweden, United Kingdom
AbbVie

Completed

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Depression | Mania | Bipolar I Disorder

United States, Bulgaria, Korea, Republic of, Malaysia, Poland, Puerto Rico, Russian Federation, Serbia, Taiwan, Thailand, Ukraine
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Tardive Dyskinesia

Japan
Indiana University
National Institute on Aging (NIA)

Terminated

The MObile AssessMENT of Behavioral and Psychological Symptoms of Dementia in Amnestic MCI and AD (MOMENT) Study (MOMENT)

Alzheimer Disease | Mild Cognitive Impairment | Mild Memory Disturbance

United States
Fundacion SEIMC-GESIDA

Active, not recruiting

Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities (MIND)

HIV Infections

Spain
ACADIA Pharmaceuticals Inc.

Active, not recruiting

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2)

Schizophrenia

Argentina, Bulgaria, Croatia, Czechia, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine
Hannover Medical School
AbbVie

Terminated

MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV

Hepatitis C, Chronic

Germany
H. Lundbeck A/S

Active, not recruiting

Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

Migraine

Japan
University Hospital, Grenoble
University Hospital, Clermont-Ferrand

Completed

Validation of the Neuropsychiatric Fluctuations Scale (EFN-VALID)) (EFN-VALID)

Parkinson Disease | Fluctuating Mood Symptoms

France
University Hospital, Toulouse

Completed

Dementia in Long Term Care Facilities: Telemedicine for the Management of Neuropsychiatric Symptoms (DETECT)

Dementia

France
Chinese University of Hong Kong

Completed

Effects of an Empowerment-based Psycho-behavioral Program on Persons With Mild Cognitive Impairment

Mild Cognitive Impairment

Hong Kong
University of California, Los Angeles

Active, not recruiting

acTBS Treatment for Inpatient Subjects With Suicidality

Suicidality

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Bipolar Disorder

United States, South Africa, Brazil, Russian Federation, France, Czechia, Croatia, India, Bulgaria
Rennes University Hospital

Completed

Apathy in Late Life Depression: New Biomarkers Using Actimetry and Magnetic Resonance Imaging (ACTIDEP)

Depression

France
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

Heart Failure, Functional and Cognitive Decline, and Psychiatric Symptoms in Nursing Home Patients

Heart Failure, Congestive

Canada
Northwell Health

Completed

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

Chronic Migraine

United States, Australia, Canada, China, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Sweden, Taiwan, United Kingdom
Social Insurance Institution, Finland
Turku University Hospital; University of Turku

Completed

A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders

ADHD | Asperger Syndrome | Child Behavior Disorders

Finland
Novartis Pharmaceuticals
Molecular Partners AG

Terminated

A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 (EMPATHY)

COVID-19

United States, India, Hungary, Netherlands, South Africa
Zogenix, Inc.

Completed

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Back Pain Lower Back Chronic

United States
New York University
Visiting Nurse Service of New York

Withdrawn

The Dementia Symptom Management at Home Program (DSM-H)

Dementia

United States
AbbVie

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Bulgaria, Estonia, Germany, Hungary, Ukraine, United Kingdom
University Health Network, Toronto
University of Toronto; University Ghent

Completed

Effect of Soundscape on People With Dementia.

Dementia | Behavioural and Psychiatric Symptoms of Dementia

Canada
University of California, Los Angeles

Completed

Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers (CARES)

Insomnia Chronic

United States
AbbVie

Completed

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Canada, Czechia, Finland, Poland, Puerto Rico, Serbia, Slovakia
University of Illinois at Chicago
National Institute of Mental Health (NIMH)

Completed

Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality (CLEAR-2)

Suicidal Ideation

United States
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease

Alzheimer's Disease

United States, Australia, Belgium, Canada, Denmark, Finland, Italy, Netherlands, New Zealand, Spain, Sweden
ACADIA Pharmaceuticals Inc.

Completed

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Neuropsychiatric Symptoms Related to Neurodegenerative Disease

United States, Russian Federation, Serbia, Poland, Georgia, Czechia, Bulgaria, Colombia, Mexico, Romania, South Africa, Ukraine
Medipol University

Completed

Cognitive Functions After COVID-19

Cognitive Decline | COVID-19 Acute Respiratory Distress Syndrome

Turkey
Mahidol University

Completed

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

Screening Tool for Depresion in Cancer Pain Patients

Thailand
University of Illinois at Chicago

Terminated

A Dissonance-Based Obesity Intervention

Obesity

United States
Region Örebro County
Örebro University, Sweden

Completed

Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)

Obsessive-Compulsive Disorder | Treatment Resistant Disorders

Sweden
Vastra Gotaland Region

Active, not recruiting

Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients (NeuMRA)

Depression | Brain Diseases | Pain | Fatigue | Rheumatoid Arthritis | Cognitive Decline | Hand Rheumatism

Sweden
Universidad Miguel Hernandez de Elche

Terminated

Mindfulness for Alzheimer Caregivers

Neurodegenerative Diseases | Dementia | Alzheimer Disease

Spain
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

22q11.2 Deletion Syndrome

United States
China Medical University Hospital

Withdrawn

Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants

Very Low Birth Weight Infants

Taiwan
H. Lundbeck A/S

Completed

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression (VIVRE)

Major Depressive Disorder

Spain, Czechia, Slovakia, Estonia, Sweden, Argentina, Belgium, Bulgaria, Latvia, Mexico, Russian Federation, Ukraine
Avanir Pharmaceuticals

Completed

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Alzheimer's Disease | Agitation

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder

United States
University Hospital, Toulouse
Ethypharm

Completed

Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study (A3C)

Alzheimer Disease

France
ACADIA Pharmaceuticals Inc.

Terminated

Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

Parkinson's Disease

United States
Neuronetics

Terminated

Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset

Depression, Postpartum

United States
Neuropsychiatrischen Zentrums Hamburg-Altona
Universitätsklinikum Hamburg-Eppendorf

Active, not recruiting

Treatment of Depression With Mindfulness, Acceptance and Commitment (MAC_Depr)

Depression | Psychotherapy

Germany
Johns Hopkins University
National Institute on Aging (NIA); Thomas Jefferson University

Completed

MIND: Care Coordination for Community-living Person With Dementia (MIND at Home)

Dementia | Caregiver Burden

United States

Search clinical trials for: neuropsychiatric symptoms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations